Arxada Provides Update on Recapitalization and Amend & Extend Transaction
Basel, Switzerland – June 22, 2026 – Herens Midco S.à r.l. (“Arxada” or the “Company”) today provided an update on the recapitalization and amend & extend transaction announced on May 12, 2026 (the “A&E Transaction”).
The Company has continued to make progress in building creditor support since launching the A&E transaction. On May 12, more than 60% of senior secured creditors had signed on to the Transaction Support Agreement (“TSA”), increasing to well over 75% by May 29. The Company is now pleased to report that it has reached an agreement in principle with a group representing over 75% of its unsecured notes (the “Senior Unsecured Noteholder Group”) to join the TSA.
To accommodate the Senior Unsecured Noteholder Group, the Company has agreed in principle to a limited number of updates to the TSA (the “TSA Amendment”) with key creditor groups. The Company is now working to implement these updates with supporting creditors.
Following completion of the TSA Amendment and the formal accession of the Senior Unsecured Noteholder Group, both expected during the week of June 22, the Company will have the approvals needed to move forward with the A&E transaction. The Company continues to target completion of the transaction in the third quarter of 2026.
The Company expects to provide a further update on the A&E transaction once the TSA Amendment is complete.
If creditors have questions about the TSA Amendment or the A&E transaction, they should contact Bain Capital, Cinven, or the Company using the details provided below.
Contact Information
Arxada
Peter Frauenknecht
cfo.arxada@arxada.com
Emily Johnson
emily.johnson@arxada.com
Bain Capital
Maria Andrisani
MAndrisani@BainCapital.com
Cinven
Christopher Anderson
Christopher.Anderson@Cinven.com
About Arxada
Arxada is a global leader in innovative solutions that protect our world. Our groundbreaking technologies, in-depth regulatory know-how, manufacturing and process development help our customers to safeguard nutrition, health and infrastructure efficiently through chemistry and microbiology that enhance sustainability. We offer a broad portfolio of ingredients and services for multiple end-markets that include Human Health & Nutrition, Home & Personal Care, Professional Hygiene, Paints & Coatings and Wood Protection. With customers in more than 100 countries, the company achieved sales of CHF 2billion in 2025. Headquartered in Basel (Switzerland), Arxada employs 3,100 associates across 24 production sites and 14 R&D centers, all committed to our customers’ success.
To learn more about Arxada, please visit: arxada.com and Arxada on LinkedIn.
Disclaimer
This announcement contains forward-looking statements. These statements include, but are not limited to, statements regarding the anticipated timing of future announcements and the implementation of the TSA Amendment and the A&E Transaction. Forward-looking statements are based on our current expectations and assumptions and are subject to risks and uncertainties, many of which are outside our control, that could cause actual results or outcomes to differ materially from those expressed or implied in those statements. No assurance can be given that the matters described in these forward-looking statements will occur as described or at all. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.